Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Keito SuzukiYutaka YasuiKaoru TsuchiyaHiroaki MatsumotoYudai YamazakiNaoki UchiharaYuki TanakaHaruka MiyamotoMichiko Yamada-ShimizuTaisei KeitokuRisa OkadaMayu HiguchiKenta TakauraShohei TanakaChiaki MaeyashikiNobuharu TamakiHiroyuki NakanishiYuka TakahashiYasuhiro AsahinaRyuichi OkamotoMasayuki KurosakiNamiki IzumiPublished in: Journal of gastroenterology and hepatology (2024)
The presence of irAEs is associated with prolonged PFS and higher DCR. Specifically, mild irAEs (grade 1/2) and hypothyroidism displayed prolonged PFS and higher DCR.
Keyphrases